a public good project by the
Synthesis
Company
of California

© 2026

Yuji Mano | doi.page

0 works0 citations0 h-index

Yuji Mano

Eisai (Japan)(JP)

Publications by Year

Research Areas

Cancer Treatment and Pharmacology, Pharmacogenetics and Drug Metabolism, Cardiovascular and Diving-Related Complications, Drug Transport and Resistance Mechanisms, Glycosylation and Glycoproteins Research

Most-Cited Works

→ The pathway of auxin biosynthesis in plants(2012)678 cited
→ Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance–associated protein 2(2006)77 cited
→ Hematocrit-Independent Recovery is A Key for Bioanalysis Using Volumetric Absorptive Microsampling Devices, Mitra Tm(2015)70 cited
→ The UDP-Glucuronosyltransferase 2B7 Isozyme Is Responsible for Gemfibrozil Glucuronidation in the Human Liver(2007)69 cited
→ Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition(2017)51 cited
→ Investigation of the high partition of YM992, a novel antidepressant, in rat brain ‐ in vitro and in vivo evidence for the high binding in brain and the high permeability at the BBB(2002)43 cited

→ Studies on carbon material requirements for bacterial proliferation and spore germination under stress conditions: a new mechanism involving transmission of physical signals(1995)

43 cited

Neurological manifestations in Japanese Ama divers.(2005)

→ High-performance liquid chromatography–tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma(2014)42 cited

→ Predominant Contribution of UDP-Glucuronosyltransferase 2B7 in the Glucuronidation of Racemic Flurbiprofen in the Human Liver(2007)39 cited